“…Biobased and biodegradable poly( l -lactide) or poly( l -lactic acid) (PLLA) (Figure ) has balanced mechanical properties, high biocompatibility, and very low toxicity appropriate for a wide range of daily necessaries and environmental, biomedical, and pharmaceutical applications . Stereocomplex (SC) formation of PLLA with its enantiomeric polymer, i.e., poly( d -lactide) or poly( d -lactic acid) (PDLA) (Figure ), is effectively utilized to widen its applications, since SC formation between enantiomeric polymers such as PLLA and PDLA homopolymers normally enhances mechanical properties and thermal and hydrolytic degradation resistance of polylactide- or poly(lactic acid) (PLA)-based materials. − With regard to poly(α-substituted 2-hydroxyalkanoic acid)s, not only enantiomeric PLLA and PDLA homopolymers but also enantiomeric lactic acid- or lactide-based random, alternating, and block copolymers − and enantiomeric substituted lactic acid-based homopolymers such as poly(2-hydroxybutanoic acid) [P(2HB)], poly(2-hydroxy-3-methylbutanoic acid) [P(2H3MB)], and poly(mandelic acid) (PMA) − were synthesized, and their SC crystallization was reported. However, as far as we are aware, synthesis and SC formation of enantiomeric stereo periodical copolymers (SPCPs) have not been reported so far, despite the expectation that their various stereosequences and SC formation can afford a wide variety of physical properties and biodegradation behavior and rate of PLA-based materials.…”